The transcriptomics market is witnessing remarkable growth, driven by an increasing understanding of gene expression and its implications for health and disease. Currently valued at USD 7.73 billion, the market is projected to reach approximately USD 16.03 billion by 2035, reflecting a robust compound annual growth rate (CAGR) of 6.85%. This growth is emblematic of a broader shift in the...

In the current landscape of 2026, the transition to high-precision molecular diagnostics has necessitated a more rigorous approach to laboratory risk management. As part of the Transcriptomics Market Global Outlook, the integration of single-cell RNA sequencing (scRNA-seq) into clinical trials has made it mandatory for labs to move beyond basic quality checks. Risk management now involves a...